GU Cancers 2020 | KRAS G12C target for urothelial carcinoma

Name: KRAS G12C target for urothelial carcinoma
Uploaded: 2020-02-16T06:59:37Z
Description: Petros Grivas, MD, PhD, University of Washington, Seattle, WA, discusses KRAS G12C as an emerging target for urothelial carcinoma and the ongoing research into this rare, although important mutation. This interview was recorded at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Petros Grivas • 16 Feb 2020

GU Cancers 2020

Bladder Cancer Genitourinary Cancer

Petros Grivas, MD, PhD, University of Washington, Seattle, WA, discusses KRAS G12C as an emerging target for urothelial carcinoma and the ongoing research into this rare, although important mutation. This interview was recorded at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.